Cardiology: ASA falls short Clinical Notes: November 2014Hypertension self-management; preventing antibiotic–sulfonylurea interactions; benzodiazepines and Alzheimer’s; updated menopause and osteoporosis guidelines. Cardiometabolic age: A new way to motivate patients Model estimates lifetime risk of diabetes and cardiovascular complications Ease up on A1C in diabetes patients with heart disease But overall risk factor management needs improvement, national study finds New consumer heart attack indication approved for Bayer’s Aspirin Bayer can now promote emergency use of Aspirin for suspected heart attack directly to consumers. Clinical Feature: NSAID risks Examining the cardiovascular safety of nonsteroidal anti-inflammatory drugs. Updated Canadian atrial fibrillation guidelines New information on stroke prevention, periprocedural anticoagulation management, rate and rhythm control. A tiny device with big potential The smallest iteration of a Canadian-invented cardiac monitor opens a bigger window on the heart New hope in heart failure ‘A new threshold of hope’ for heart failure patients Investigative drug reduces death and hospitalization, trial shows First Previous 43 44 45 46 47 Next Last
